The Nampt mutant transgenic mice exhibited significantly decreased NAD levels, mediated by a decrease in Nampt activity throughout the body, causing hepatopathy, including inflammation, fibrosis, lipid homeostasis imbalance, and steatosis [7]. This evidence concerns the gene NAMPT and steatosis.